Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ENDO PHARMACEUTICALS INC. v. ACTAVIS INC. et al
Case Number:
2:12-cv-07591
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 14, 2016
Endo's False Ad Claims Against Actavis Tossed For Good
A New Jersey federal judge on Tuesday dismissed with prejudice Endo Pharmaceuticals Inc.'s false marketing lawsuit against Actavis Inc. in the wake of a related patent infringement judgment in New York federal court that bars Actavis from selling a generic version of Endo's painkiller Opana ER.
-
September 13, 2016
Actavis Wants False Ad Claims Dismissed With Prejudice
Drugmaker Actavis Inc. asked a New Jersey federal judge Tuesday to deny Endo Pharmaceuticals Inc.'s request to dismiss without prejudice Endo's false marketing suit over generic versions of its painkiller Opana ER, saying the claims should instead be tossed with prejudice so that Endo can't turn around and sue again.
-
March 21, 2016
Endo's Consumer Fraud Claim Tossed In Actavis False Ad Suit
A New Jersey federal judge on Monday tossed Endo Pharmaceuticals Inc.'s claim that Actavis Inc. violated the New Jersey Consumer Fraud Act in its false marketing suit over generic versions of painkiller Opana ER, saying that as a competitor of Actavis, Endo lacks standing to bring that claim.
-
February 23, 2016
Actavis Says Endo Cites Wrong Precedent In False Ad Suit
Endo Pharmaceuticals Inc. can't rely on the U.S. Supreme Court's 2014 Pom Wonderful decision to claim that its suit against Actavis Inc. over generic versions of the painkiller Opana ER is allowed under the federal false advertising statute, Actavis told a New Jersey federal court Monday.
-
September 04, 2013
Actavis Ducks Endo's Opana False Ad Suit In NJ
A New Jersey federal judge on Tuesday nixed a false advertising and consumer fraud suit brought by Endo Pharmaceuticals Inc. against Actavis Inc. over generic versions of its Opana ER painkiller, saying he would defer to the Food and Drug Administration on a key issue over the drug's formulation.